Karela

<h3> Absolute Contraindications of Karela (Momordica charantia) </h3> <h4> Pregnancy / Trying to conceive (risk to fetus and pregnancy)[In layman terms]</h4> <ul> <li>🤰</li> <li>Recommendation: Do not use karela extracts, concentrated juices, or seed preparations during pregnancy or if you are trying to conceive; avoid large or medicinal doses. Consult your OB/GYN if you already used it. </li> <li>Reasoning: Seed proteins and some extracts have shown abortifacient and teratogenic effects in animal studies and can impair uterine/embryonic processes, so use in pregnancy is unsafe based on experimental evidence.</li> <li>Scientific_Study_Title: Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats</li> <li>Scientific_Study_Authors: Uche-Nwachi EO, McEwen C</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21304609/</li> <li>Scientific_Study_Excerpt: <p>The animal study administered water extract of unripe fruit during organogenesis and found a higher rate of malformed litters and fetal resorptions versus controls. The treated group showed a notable proportion of malformations and evidence of developmental toxicity compared with the untreated group.</p> <p>Authors concluded that the extract produced teratogenic effects in this rat model and recommended caution about use during pregnancy.</p> </li> </ul> <h4>Known or suspected allergy / severe hypersensitivity to Momordica components [In layman terms]</h4> <ul> <li>⚠️</li> <li>Recommendation: If you have experienced hives, breathing trouble, angioedema, or sudden systemic reactions after eating or taking bitter gourd or related plant products, avoid it and seek urgent care for any new severe reaction.</li> <li>Reasoning: Isolated bitter-gourd proteins (e.g., alpha-momorcharin) are highly immunogenic in animal studies and can cause strong immune responses and organ toxicity at higher exposures.</li> <li>Scientific_Study_Title: Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats</li> <li>Scientific_Study_Authors: (as indexed) [authors listed on PubMed entry]</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22172326/</li> <li>Scientific_Study_Excerpt: <p>Animal experiments with purified alpha-momorcharin (a seed ribosome-inactivating protein) showed strong immune responses and evidence of organ toxicity, including focal liver cell changes and hematologic abnormalities with higher dosing and repeated exposure.</p> <p>The study warns that potent immunogenic proteins from the plant can cause significant adverse systemic and organ effects in experimental models, supporting caution in people prone to hypersensitivity.</p> </li> </ul> <h4>Children and infants (risk of severe hypoglycemia and neurological events) [In layman terms]</h4> <ul> <li>👶</li> <li>Recommendation: Avoid giving concentrated bitter gourd extracts or large amounts of karela juice to children or infants. If a child has unusual drowsiness, seizures, or loss of consciousness after exposure, seek emergency care.</li> <li>Reasoning: Reports and safety summaries note rare but serious events (severe hypoglycemia, coma, convulsions) in children exposed to high amounts or medicinal preparations of bitter gourd.</li> <li>Scientific_Study_Title: Bitter Melon - LiverTox clinical summary (safety profile and reported adverse events)</li> <li>Scientific_Study_Authors: NIH / LiverTox editorial contributors (NCBI Bookshelf)</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK590483/</li> <li>Scientific_Study_Excerpt: <p>LiverTox summarizes that while most clinical studies report mild tolerability, rare but serious adverse events after bitter melon exposure include severe hypoglycemia, coma, and seizures-particularly notable in pediatric exposures or when high/therapeutic doses are used.</p> <p>The resource therefore advises avoiding medicinal doses in children and pregnant women and highlights instances of severe neurologic sequelae linked to hypoglycemia from concentrated preparations.</p> </li> </ul> <h4>High-dose seed/isolated protein preparations (research or concentrated extracts) [In layman terms]</h4> <ul> <li>🧪</li> <li>Recommendation: Do not use seed-derived concentrates or isolated proteins outside controlled research settings; avoid self-made concentrated seed extracts.</li> <li>Reasoning: Purified seed proteins (momorcharins) are biologically active and at sufficient doses have produced immunotoxicity, endometrial/decidual inhibition and organ effects in animal models.</li> <li>Scientific_Study_Title: The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia)</li> <li>Scientific_Study_Authors: Leung SO, Yeung HW, Leung KN (as indexed)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/3497134/</li> <li>Scientific_Study_Excerpt: <p>Purified alpha- and beta-momorcharin from seeds suppressed various immune responses in vitro and altered reproductive tissue behavior in animal models. In vivo dosing produced depressed cell-mediated and humoral immune responses and changes consistent with abortifacient activity in experimental animals.</p> <p>The study highlights the biological potency of isolated seed proteins and supports avoidance of such concentrated seed preparations outside research contexts.</p> </li> </ul> <h3> Relative Contraindications of Karela (Momordica charantia) </h3> <h4>Concurrent use with statin drugs (example: rosuvastatin) - caution for altered drug kinetics</h4> <ul> <li>💊</li> <li>Recommendation: If you take statins, consult your prescriber before starting concentrated karela supplements; monitor for side effects and consider temporary avoidance until interactions are assessed.</li> <li>Reasoning: Animal and in vivo work indicate that some bitter-melon extracts can alter pharmacokinetics of co-administered drugs (shortening half-life and changing elimination), so combination may change drug exposure.</li> <li>Scientific_Study_Title: In Vitro and In Vivo Evaluation of Rosuvastatin and Momordica charantia (Bitter Melon) Extract: Pharmacokinetic Interactions and Anticancer Potential</li> <li>Scientific_Study_Authors: (authors as indexed on PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/40849723/</li> <li>Scientific_Study_Excerpt: <p>In rat pharmacokinetic experiments, co-administration of M. charantia extract significantly shortened rosuvastatin's half-life and increased elimination rate without altering Cmax or AUC in the model used. Authors note potential for M. charantia to alter drug metabolism/clearance and recommend further clinical study to define relevance to humans.</p> </li> </ul> <h4>Concurrent use with tyrosine kinase inhibitors (example: pazopanib) - possible serious interaction</h4> <ul> <li>⚠️</li> <li>Recommendation: If you are taking pazopanib or similar anticancer drugs, avoid karela supplements and discuss with your oncology team before use.</li> <li>Reasoning: A published case report linked short-term use of bitter-melon extract with acute pancreatitis in a patient on long-term pazopanib, suggesting a probable herb-drug interaction; this may be serious.</li> <li>Scientific_Study_Title: Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis</li> <li>Scientific_Study_Authors: (authors as indexed on PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34569860/</li> <li>Scientific_Study_Excerpt: <p>The case report describes a 65-year-old on pazopanib who developed acute pancreatitis after four days of bitter melon extract intake; extremely elevated amylase and lipase were recorded. Stopping bitter melon and holding pazopanib allowed recovery, and re-challenge with pazopanib alone did not recreate pancreatitis, implicating a probable interaction.</p> </li> </ul> <h4>Use with drugs metabolized by hepatic enzymes (possible CYP modulation)</h4> <ul> <li>⚖️</li> <li>Recommendation: For drugs with narrow therapeutic windows metabolized by CYP enzymes (e.g., some immunosuppressants, anticoagulants, antiepileptics), consult a clinician and consider monitoring levels if starting/stopping concentrated karela supplements.</li> <li>Reasoning: Animal studies show karela juice can modulate hepatic cytochrome P450 activities and other drug-metabolizing enzymes, potentially changing how co-medications are processed.</li> <li>Scientific_Study_Title: Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats</li> <li>Scientific_Study_Authors: (authors as indexed on PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8937480/</li> <li>Scientific_Study_Excerpt: <p>In diabetic rat models, feeding bitter-melon fruit juice altered activities of several hepatic drug-metabolizing enzymes (increasing or decreasing specific monooxygenase activities). The authors note that such modulation could influence concomitant drug metabolism and recommend caution in co-administration settings.</p> </li> </ul>